Fundraising Fox

Semma Therapeutics

Cambridge, US · Founded 2014 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

KT
Kingsley TaftExecutive Officer
TF
Todd FoleyExecutive Officer, Director
WS
William SahlmanDirector
MF
Mitch FinerDirector
RM
Robert MillmanExecutive Officer, Director
JS
Jim ScopaDirector
SK
Stephen KnightDirector

Investors · 1

F-Prime Capital PartnersCambridge · $3M – $10M

Reported raises · per SEC filings

Form D private placements
▶$113.9MraisedFeb 2019 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kingsley TaftExecutive Officer
  • Todd FoleyExecutive Officer, Director
  • Kevin RaidyDirector
  • Daniel AuerbachDirector
  • William SahlmanDirector
  • Mitchell FinerDirector
  • Mark FishmanDirector
  • Stephen KnightDirector
  • Bastiano SannaExecutive Officer, Director
Offering amount
$119.9M
Amount sold
$113.9M
First sale
Nov 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.4MraisedMar 2016 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kingsley TaftExecutive Officer
  • Todd FoleyExecutive Officer, Director
  • William SahlmanDirector
  • Mitch FinerDirector
  • Stephen KnightDirector
  • Robert MillmanExecutive Officer, Director
  • Jim ScopaDirector
Offering amount
$25M
Amount sold
$15.4M
First sale
Mar 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.